Cargando…

Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species

Clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 genome modification systems have greatly facilitated the genetic analysis of fungal pathogens. In CRISPR-Cas9 genome editing methods designed for use in Candida albicans, DNAs that encode the necessary components are expressed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Grahl, Nora, Demers, Elora G., Crocker, Alex W., Hogan, Deborah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480035/
https://www.ncbi.nlm.nih.gov/pubmed/28657070
http://dx.doi.org/10.1128/mSphere.00218-17
_version_ 1783245220742168576
author Grahl, Nora
Demers, Elora G.
Crocker, Alex W.
Hogan, Deborah A.
author_facet Grahl, Nora
Demers, Elora G.
Crocker, Alex W.
Hogan, Deborah A.
author_sort Grahl, Nora
collection PubMed
description Clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 genome modification systems have greatly facilitated the genetic analysis of fungal pathogens. In CRISPR-Cas9 genome editing methods designed for use in Candida albicans, DNAs that encode the necessary components are expressed in the target cells. Unfortunately, expression constructs that work efficiently in C. albicans are not necessarily expressed well in other pathogenic species within the genus Candida or the related genus Clavispora. To circumvent the need for species-specific expression constructs, we implemented an expression-free CRISPR genome editing system and demonstrated its successful use in three different non-albicans Candida species: Candida (Clavispora) lusitaniae, Candida glabrata, and Candida auris. In CRISPR-Cas9-mediated genome editing methods, a targeted double-stranded DNA break can be repaired by homologous recombination to a template designed by the investigator. In this protocol, the DNA cleavage is induced upon transformation of purified Cas9 protein in complex with gene-specific and scaffold RNAs, referred to as RNA-protein complexes (RNPs). In all three species, the use of RNPs increased both the number of transformants and the percentage of transformants in which the target gene was successfully replaced with a selectable marker. We constructed mutants defective in known or putative catalase genes in C. lusitaniae, C. glabrata, and C. auris and demonstrated that, in all three species, mutants were more susceptible to hydrogen peroxide than the parental strain. This method, which circumvents the need for expression of CRISPR-Cas9 components, may be broadly useful in the study of diverse Candida species and emergent pathogens for which there are limited genetic tools. IMPORTANCE Existing CRISPR-Cas9 genome modification systems for use in Candida albicans, which rely on constructs to endogenously express the Cas9 protein and guide RNA, do not work efficiently in other Candida species due to inefficient promoter activity. Here, we present an expression-free method that uses RNA-protein complexes and demonstrate its use in three Candida species known for their drug resistance profiles. We propose that this system will aid the genetic analysis of fungi that lack established genetic systems.
format Online
Article
Text
id pubmed-5480035
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-54800352017-06-27 Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species Grahl, Nora Demers, Elora G. Crocker, Alex W. Hogan, Deborah A. mSphere Research Article Clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 genome modification systems have greatly facilitated the genetic analysis of fungal pathogens. In CRISPR-Cas9 genome editing methods designed for use in Candida albicans, DNAs that encode the necessary components are expressed in the target cells. Unfortunately, expression constructs that work efficiently in C. albicans are not necessarily expressed well in other pathogenic species within the genus Candida or the related genus Clavispora. To circumvent the need for species-specific expression constructs, we implemented an expression-free CRISPR genome editing system and demonstrated its successful use in three different non-albicans Candida species: Candida (Clavispora) lusitaniae, Candida glabrata, and Candida auris. In CRISPR-Cas9-mediated genome editing methods, a targeted double-stranded DNA break can be repaired by homologous recombination to a template designed by the investigator. In this protocol, the DNA cleavage is induced upon transformation of purified Cas9 protein in complex with gene-specific and scaffold RNAs, referred to as RNA-protein complexes (RNPs). In all three species, the use of RNPs increased both the number of transformants and the percentage of transformants in which the target gene was successfully replaced with a selectable marker. We constructed mutants defective in known or putative catalase genes in C. lusitaniae, C. glabrata, and C. auris and demonstrated that, in all three species, mutants were more susceptible to hydrogen peroxide than the parental strain. This method, which circumvents the need for expression of CRISPR-Cas9 components, may be broadly useful in the study of diverse Candida species and emergent pathogens for which there are limited genetic tools. IMPORTANCE Existing CRISPR-Cas9 genome modification systems for use in Candida albicans, which rely on constructs to endogenously express the Cas9 protein and guide RNA, do not work efficiently in other Candida species due to inefficient promoter activity. Here, we present an expression-free method that uses RNA-protein complexes and demonstrate its use in three Candida species known for their drug resistance profiles. We propose that this system will aid the genetic analysis of fungi that lack established genetic systems. American Society for Microbiology 2017-06-21 /pmc/articles/PMC5480035/ /pubmed/28657070 http://dx.doi.org/10.1128/mSphere.00218-17 Text en Copyright © 2017 Grahl et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Grahl, Nora
Demers, Elora G.
Crocker, Alex W.
Hogan, Deborah A.
Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species
title Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species
title_full Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species
title_fullStr Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species
title_full_unstemmed Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species
title_short Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species
title_sort use of rna-protein complexes for genome editing in non-albicans candida species
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480035/
https://www.ncbi.nlm.nih.gov/pubmed/28657070
http://dx.doi.org/10.1128/mSphere.00218-17
work_keys_str_mv AT grahlnora useofrnaproteincomplexesforgenomeeditinginnonalbicanscandidaspecies
AT demerselorag useofrnaproteincomplexesforgenomeeditinginnonalbicanscandidaspecies
AT crockeralexw useofrnaproteincomplexesforgenomeeditinginnonalbicanscandidaspecies
AT hogandeboraha useofrnaproteincomplexesforgenomeeditinginnonalbicanscandidaspecies